SCHEMBL27419683

SCHEMBL27419683

CCCCCC(CC)SCCCCCC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.57
FFAR1 O14842 2/20 0.57
PPARG P37231 8/20 0.55
GPR84 Q9NQS5 7/20 0.55
PPARD Q03181 7/20 0.55
PPARA Q07869 7/20 0.55
HDAC11 Q96DB2 5/20 0.55
TSHR P16473 4/20 0.55
PTPN1 P18031 3/20 0.55
ALDH1A1 P00352 2/20 0.55
TLR2 O60603 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
FABP4 P15090 2/20 0.55
KMT2A Q03164 2/20 0.55
SLC22A6 Q4U2R8 1/20 0.55
SLC22A8 Q8TCC7 1/20 0.55
MEN1 O00255 1/20 0.55
ESR1 P03372 1/20 0.55
ALOX15 P16050 1/20 0.55
PDE4A P27815 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1603630 0.90 FFAR4 (0.57) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL17670559 0.90 FFAR4 (0.51) FFAR4FFAR1PPARGGPR84PPARD
Methane SCHEMBL25432262 0.89 FFAR4 (0.50) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL18211189 0.87 FFAR4 (0.61) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL27430307 0.86 GPR84 (0.50) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL18211006 0.85 FFAR4 (0.59) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL7599239 0.85 GPR84 (0.52) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL18699066 0.84 EPHX1 (0.42) GPR84TSHR
SCHEMBL18771047 0.84 FFAR4 (0.57) FFAR4FFAR1PPARGGPR84PPARD
SCHEMBL30132370 0.83 FFAR4 (0.61) FFAR4FFAR1PPARGGPR84PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207178-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207178-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS CHMP4B, LIPA, NPC1L1 FFAR4 1823/4885FFAR1 1642/4885PPARG 538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.